These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

834 related articles for article (PubMed ID: 27800591)

  • 1. Unmet needs and current and future approaches for osteoporotic patients at high risk of hip fracture.
    Ferrari S; Reginster JY; Brandi ML; Kanis JA; Devogelaer JP; Kaufman JM; Féron JM; Kurth A; Rizzoli R
    Arch Osteoporos; 2016 Dec; 11(1):37. PubMed ID: 27800591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fracture prevention service to bridge the osteoporosis care gap.
    Ruggiero C; Zampi E; Rinonapoli G; Baroni M; Serra R; Zengarini E; Baglioni G; Duranti G; Ercolani S; Conti F; Caraffa A; Mecocci P; Brandi ML
    Clin Interv Aging; 2015; 10():1035-42. PubMed ID: 26150707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Post-fracture care gap: a retrospective population-based analysis of Hong Kong from 2009 to 2012.
    Cheung MY; Ho AW; Wong SH
    Hong Kong Med J; 2018 Dec; 24(6):579-583. PubMed ID: 30449735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Orthopedic-Metabolic Collaborative Management for Osteoporotic Hip Fracture.
    Rotman-Pikielny P; Frankel M; Lebanon OT; Yaacobi E; Tamar M; Netzer D; Nabriski D; Nyska M; Brin YS
    Endocr Pract; 2018 Aug; 24(8):718-725. PubMed ID: 30084682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. After the fall: improving osteoporosis treatment following hip fracture.
    Kuiper BW; Graybill S; Tate JM; Kaufman N; Bersabe D
    Osteoporos Int; 2018 Jun; 29(6):1295-1301. PubMed ID: 29464276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Visualisation of the unmet treatment need of osteoporotic fracture in Taiwan: A nationwide cohort study.
    Wang CY; Fu SH; Huang CC; Hung CC; Yang RS; Hsiao FY
    Int J Clin Pract; 2018 Oct; 72(10):e13246. PubMed ID: 30144247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Application of guidelines for secondary prevention of fracture and the FRAX index in patients with fragility fracture].
    Naranjo A; Ojeda-Bruno S; Francisco-Hernández F; Erausquin C; Rúa-Figueroa I; Rodríguez-Lozano C
    Med Clin (Barc); 2011 Mar; 136(7):290-2. PubMed ID: 21185575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of osteoporosis in patients hospitalized for hip fractures.
    Ip TP; Leung J; Kung AW
    Osteoporos Int; 2010 Dec; 21(Suppl 4):S605-14. PubMed ID: 21058000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of bone protection and associated fragility injuries in patients with proximal femur fractures.
    Aguado-Maestro I; Panteli M; García-Alonso M; Bañuelos-Díaz A; Giannoudis PV
    Injury; 2017 Dec; 48 Suppl 7():S27-S33. PubMed ID: 28851521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of osteoporotic treatment on the functional outcome, re-fracture rate, quality of life and mortality in patients with hip fractures: a prospective functional and clinical outcome study on 520 patients.
    Makridis KG; Karachalios T; Kontogeorgakos VA; Badras LS; Malizos KN
    Injury; 2015 Feb; 46(2):378-83. PubMed ID: 25541417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What is a reasonable rate for specific osteoporosis drug therapy in older fragility fracture patients?
    Gosch M; Bail HJ; Grueninger S; Stumpf U; Kammerlander C; Wicklein S
    Arch Osteoporos; 2020 Feb; 15(1):20. PubMed ID: 32088765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of bisphosphonates for prevention of fracture related to glucocorticoid-induced osteoporosis in Malaysia.
    Mohd-Tahir NA; Thomas P; Mohamed-Said MS; Makmor-Bakry M; Li SC
    Int J Rheum Dis; 2018 Mar; 21(3):647-655. PubMed ID: 29105349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and management of patients at increased risk of osteoporotic fracture: outcomes of an ESCEO expert consensus meeting.
    Kanis JA; Cooper C; Rizzoli R; Abrahamsen B; Al-Daghri NM; Brandi ML; Cannata-Andia J; Cortet B; Dimai HP; Ferrari S; Hadji P; Harvey NC; Kraenzlin M; Kurth A; McCloskey E; Minisola S; Thomas T; Reginster JY;
    Osteoporos Int; 2017 Jul; 28(7):2023-2034. PubMed ID: 28451733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fracture Liaison Service for Hip Fractures: Is It A Game Changer?
    Or O; Fisher Negev T; Hadad V; Shabtai R; Katzir A; Weil Y; Liebergall M
    Isr Med Assoc J; 2021 Aug; 23(8):490-493. PubMed ID: 34392623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outpatient management of the elderly patient following fragility hip fracture.
    Sanders S; Geraci SA
    Am J Med; 2011 May; 124(5):408-10. PubMed ID: 21531228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of patients at very high risk of osteoporotic fractures through sequential treatments.
    Curtis EM; Reginster JY; Al-Daghri N; Biver E; Brandi ML; Cavalier E; Hadji P; Halbout P; Harvey NC; Hiligsmann M; Javaid MK; Kanis JA; Kaufman JM; Lamy O; Matijevic R; Perez AD; Radermecker RP; Rosa MM; Thomas T; Thomasius F; Vlaskovska M; Rizzoli R; Cooper C
    Aging Clin Exp Res; 2022 Apr; 34(4):695-714. PubMed ID: 35332506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health-economic comparison of three recommended drugs for the treatment of osteoporosis.
    Brecht JG; Kruse HP; Möhrke W; Oestreich A; Huppertz E
    Int J Clin Pharmacol Res; 2004; 24(1):1-10. PubMed ID: 15575171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Underutilization of antiosteoporotic drugs by orthopedic surgeons for prevention of a secondary osteoporotic fracture.
    Iba K; Takada J; Hatakeyama N; Kaya M; Isogai S; Tsuda H; Obata H; Miyano S; Yamashita T
    J Orthop Sci; 2006 Oct; 11(5):446-9. PubMed ID: 17013730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A 2-year follow-up of a novel Fracture Liaison Service: can we reduce the mortality in elderly hip fracture patients? A prospective cohort study.
    González-Quevedo D; Pérez-Del-Río V; Moriel-Garceso D; Fernández-Arroyabe N; García-Meléndez G; Montañez-Ruiz M; Bravo-Bardají M; García-de-Quevedo D; Tamimi I
    Osteoporos Int; 2022 Aug; 33(8):1695-1702. PubMed ID: 35357521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteoporosis in the European Union: medical management, epidemiology and economic burden. A report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA).
    Hernlund E; Svedbom A; Ivergård M; Compston J; Cooper C; Stenmark J; McCloskey EV; Jönsson B; Kanis JA
    Arch Osteoporos; 2013; 8(1):136. PubMed ID: 24113837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.